Bevacizumab (Avastin) as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: A prospective case series

Ophthalmic Research

Volumn 45, Issue 1, 2010, Pages 23-30

  Abdelhakim, Mohamad Amr Salah Eddin ^a   MacKy, Tamer A ^a,b   Mansour, Khaled Abdel Galil ^a   Mortada, Hassan Ali ^a  

^a Cairo University   (Egypt)

^b NONE   (Egypt)

Author keywords

Bevacizumab; Proliferative diabetic retinopathy; Vitrectomy

Indexed keywords

BEVACIZUMAB;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ARTICLE; DEMOGRAPHY; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; HYPERTENSION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA HEMORRHAGE; SEX RATIO; VISUAL ACUITY; VITRECTOMY;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITRECTOMY; YOUNG ADULT;

EID: 77955545498     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314721     Document Type: Article

References (20)

1. Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ, Wendel R, Patel A: Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006; 113: 1695.
2. Jorge R, Costa RA, Calioli D, Cintra LP, Scott IU: Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study). Retina 2006; 26: 1006-1013.
3. Spaide RF, Fisher YL: Intravitreal bevacizumab (Avastin) treatment of proliferative retinopathy complicated by vitreous hemorrhage. Retina 2006; 26: 275-278.
4. Chen E, Park CH: Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy. Retina 2006; 26: 699-700.
5. Yeoh J, Williams C, Allen P, Buttery R, Chiu D, Clark B, Essex R, McCombe M, Qureshi S, Campbell WG: Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series. Clin Exp Ophthalmol 2008; 36: 449-454.
6. Rizzo S, Genovesi-Ebert F, Di Bartolo E, Vento A, Miniaci S, Williams G: Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR). Graefes Arch Clin Exp Ophthalmol 2008; 246: 837-842.
7. El-Batarny AM: Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy. Clin Ophthalmol 2008; 2: 709-716.
8. Yang CM, Yeh PT, Yang CH, Chen MS: Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy. Am J Ophthalmol 2008; 146: 211-217.
9. Romano MR, Gibran SK, Marticorena J, Wong D, Heimann H: Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous hemorrhage? Eye 2009; 23: 1698-1701.
10. Yeh PT, Yang CM, Lin YC, Chen MS, Yang CH: Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy. Retina 2009; 29: 768-774.
11. Lo WR, Kim SJ, Aaberg TM Sr, Bergstrom C, Srivastava SK, Yan J, Martin DF, Hubbard GB 3rd: Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (Avastin). Retina 2009; 29: 926-931.
12. da R Lucena D, Ribeiro JA, Costa RA, Barbosa JC, Scott IU, de Figueiredo-Pontes LL, Jorge R: Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study). Br J Ophthalmol 2009; 93: 688-691.
13. Yeung L, Liu L, Wu WC, Kuo YH, Chao AN, Chen KJ, Yang KJ, Chen TL, Lai CC: Reducing the incidence of early postoperative vitreous hemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment. Acta Ophthalmol 2009, E-pub ahead of print.
14. Ahmadieh H, Shoeibi N, Entezari M, Monshizadeh R: Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial. Ophthalmology 2009; 116: 1943-1948.
15. Oshima Y, Shima C, Wakabayashi T, Kusaka S, Shiraga F, Ohji M, Tano Y: Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment. Ophthalmology 2009; 116: 927-938.
16. Modarres M, Nazari H, Falavarjani KG, Naseripour M, Hashemi M, Parvaresh MM: Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy. Eur J Ophthalmol 2009; 19: 848-852.
17. Ishikawa K, Honda S, Tsukahara Y, Negi A: Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy. Eye (Lond) 2009; 23: 108-111.
18. Di Lauro R, de Ruggiero P, di Lauro R, di Lauro MT, Romano MR: Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2010; 248: 785-791.
19. Romano MR, Gibran SK, Marticorena J, Wong D, Heimann H: Can an intraoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous hemorrhage? Eur J Ophthalmol 2009; 19: 618-621.
20. Yeh PT, Yang CH, Yang CM: Intravitreal bevacizumab injection for recurrent vitreous hemorrhage after diabetic vitrectomy. Acta Ophthalmol 2010, E-pub ahead of print.